Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973379-25-000179
Filing Date
2025-06-03
Accepted
2025-06-03 15:59:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2948
  Complete submission text file 0001973379-25-000179.txt   4481
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-16174 | Film No.: 251019183
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TEVA 5 BASEL STREET, P.O. BOX 3190 PETACH TIKVA L3 4951033
Business Address
Shields Matthew (Reporting) CIK: 0002025621 (see all company filings)

Type: 144